Monogenic neurodevelopmental disorders provide key insights into the pathogenesis of disease and help us understand how specific genes control the development of the human brain. Timothy syndrome is caused by a missense mutation in the L-type calcium channel Ca v 1.2 that is associated with developmental delay and autism 1 . We generated cortical neuronal precursor cells and neurons from induced pluripotent stem cells derived from individuals with Timothy syndrome. Cells from these individuals have defects in calcium (Ca 2+ ) signaling and activity-dependent gene expression. They also show abnormalities in differentiation, including decreased expression of genes that are expressed in lower cortical layers and in callosal projection neurons. In addition, neurons derived from individuals with Timothy syndrome show abnormal expression of tyrosine hydroxylase and increased production of norepinephrine and dopamine. This phenotype can be reversed by treatment with roscovitine, a cyclin-dependent kinase inhibitor and atypical L-type-channel blocker [2] [3] [4] . These findings provide strong evidence that Ca v 1.2 regulates the differentiation of cortical neurons in humans and offer new insights into the causes of autism in individuals with Timothy syndrome.
Human genetic studies have implicated voltage-gated calcium channels, in particular the L-type channel Ca v 1.2, in the development of psychiatric diseases such as autism 5 , bipolar disorder 6 and schizophrenia 7 . Although calcium influx through these channels is crucial for a variety of neuronal processes including regulation of gene expression 8 , the cellular defects caused by mutations in these channels and how they lead to psychiatric symptoms is unknown. Timothy syndrome is caused by a point mutation in an alternatively spliced exon of CACNA1C, the gene that encodes the α 1 subunit of Ca v 1. 2 (ref. 1) . This mutation leads to decreased calcium-and voltage-dependent inactivation of the channel 1, 9 . Individuals with Timothy syndrome suffer from cardiac arrhythmia, hypoglycemia and global developmental delay. Over 60% of individuals with Timothy syndrome also fulfill the criteria for an autism spectrum disorder (ASD) 1 making Timothy syndrome one of the most penetrant monogenic forms of autism.
To determine the cellular consequences of the mutation causing Timothy syndrome, we used somatic cell reprogramming 10, 11 to generate induced pluripotent stem cells (iPSCs) from individuals with Timothy syndrome (see Supplementary Figs. 1 and 2 , Supplementary Methods and ref. 12 for characterization of these cells and Supplementary Table 1 for a list of the cell lines used in each experiment). We differentiated the iPSC lines into neuronal precursor cells (NPCs) and neurons using conditions that favor the generation of cortical neurons [13] [14] [15] (see Fig. 1, Supplementary Fig. 3 , Online Methods and Supplementary Methods for details about the in vitro differentiation process). To identify the types of cells in these cultures, we used Fluidigm Dynamic Arrays 16 to measure the expression of region-specific and cell-type-specific marker genes in single cells ( Fig. 1b and Supplementary Table 2 ). We verified the reliability and accuracy of this method in measuring single-cell gene expression in a variety of ways (ref. 17 , Supplementary Figs. 4 and 5 and Supplementary Methods). Overall, in cultures derived from control subjects, 64.9% of the cells at day 45 of differentiation in vitro expressed a neuronal marker (MAP2 or NCAM). Individual neurons expressed combinations of genes that indicate their neurotransmitter identity and cortical-layer specificity ( Fig. 1b) . A substantial number of neurons expressed excitatory markers such as those encoded by SLC17A7 (also known as VGLUT1) and SLC17A6 (also known as VGLUT2) along with the dopamine receptor encoded by DRD2, whereas other neurons expressed the inhibitory markers encoded by GAD2 (also known as GAD65), GAD1 (also known as GAD67) and SLC32A1 (also known as VGAT).
We sought to determine the cortical layer identity of the neurons in these iPSC-derived cultures, by examining the distribution of layer-specific marker genes using single cell Fluidigm arrays. We chose markers that have been characterized immunohistochemically in human brain (refs. 18,19) (Fig. 1c) . We classified cells as Using iPSC-derived neurons to uncover cellular phenotypes associated with Timothy syndrome lower-layer cortical neurons if they expressed ETV1, FOXP1 or both in addition to NCAM or MAP2. We classified these cells as upper-layer cortical neurons if they failed to express either ETV1 or FOXP1 but expressed at least one cortical layer marker such as CUX1, SATB2, BCL11B (also called CTIP2) or RELN. We found that ~85% of the neurons derived from control subjects could be classified as lower cortical-layer neurons while the remaining 15% were upper cortical cells (Fig. 1d) . Within the population of lower cortical neurons, we found a group of cells that co-expressed CTIP2 (BCL11B) in addition to ETV1 and/or FOXP1 (Fig. 1e) . In vivo, this distribution of markers defines a population of subcortical projection neurons [20] [21] [22] . Our cultures also contained a population of cells that expressed SATB2 and ETV1 and/or FOXP1, which in vivo defines a group of neurons that projects to distant cortical regions through the corpus callosum [20] [21] [22] (Fig. 1d) . A notable finding from this analysis was the reproducibility of neuronal differentiation across multiple iPSC lines and individuals (the average s.d. for the proportion of cells expressing a particular marker was 4.5%), indicating that this process is highly reproducible in vitro and that single-cell analysis of gene expression can be used to identify abnormalities in neuronal differentiation.
The ability to generate well-defined populations of NPCs and neurons from iPSCs prompted us to ask whether we could identify cellular phenotypes associated with Timothy syndrome. We examined the total number of neurons (Supplementary Fig. 5 ) and the proliferation Forebrain Progenitors (i) Average [Ca 2+ ] i measurements in synapsin-1-expressing neurons depolarized twice with 67 mM KCl and treated with 5 µM nimodipine (n = 10 neurons for Timothy syndrome and n = 9 neurons for control). (j) Histogram of residual [Ca 2+ ] i in single cells, computed by dividing the plateau calcium level by the peak calcium elevation ((C − A) / (B − A) as shown in i; three Timothy syndrome lines and three control lines; t test, P < 0.0001; see also Supplementary Fig. 8 ). Fig. 6a ) and migration ( Supplementary Fig. 6b,c) of NPCs, but we found no differences between cultures from controls and those from individuals with Timothy syndrome. We next used patchclamp recording and calcium imaging to assess the physiological properties of neurons generated from the iPSC lines ( Fig. 1f) . Fiftyseven percent of the iPSC-derived cells fired mature action potentials ( Supplementary Fig. 7) . A comparison of Timothy syndrome and control neurons did not reveal any significant differences in the action potential threshold or amplitude, resting membrane potential, input resistance or capacitance ( Supplementary  Table 3 ). However, the action potentials of Timothy syndrome neurons were approximately 37% wider at the midpoint than those of controls (3.92 ms ± 0.49 ms (mean ± s.e.m.) for Timothy syndrome compared to 2.86 ms ± 0.12 ms for control; P = 0.008), which is consistent with a loss of channel inactivation in Timothy syndrome ( Fig. 1f,g) and is similar to the defect we observed in iPSC-derived cardiomyocytes from individuals with Timothy syndrome 12 .
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We next examined the intracellular calcium ([Ca 2+ ] i ) signals in Timothy syndrome and control NPCs and neurons using the calcium indicator Fura-2 and time-lapse video microscopy. Because the cultures contained a mixed population of neurons and NPCs, we first measured [Ca 2+ ] i in mature neurons expressing a yellow fluorescent protein (YFP) reporter gene under the control of the synapsin-1 promoter (Fig. 1h) . In Timothy syndrome cells, we observed a significant increase in the sustained [Ca 2+ ] i rise after depolarization that was abolished by treatment with the L-type calcium channel blocker nimodipine (Fig. 1i) . We observed this increased [Ca 2+ ] i rise also in nonlabeled Timothy syndrome neurons derived from multiple lines and multiple independent differentiations ( Fig. 1j and Supplementary Fig. 8a,b) . Similarly, we observed increased [Ca 2+ ] i elevations in Timothy syndrome NPCs ( Supplementary Fig. 8c,d) . Taken together, these results provide strong evidence that NPCs and neurons derived from individuals with Timothy syndrome have defects in action potential firing and [Ca 2+ ] i signaling.
Ca V 1.2 has a key role in regulating activity-dependent gene expression in the nervous system 8 . We therefore used Illumina microarrays to compare the gene expression profiles of Timothy syndrome and control NPCs and neurons ( Fig. 2a-d) . Hierarchical clustering based on differentially expressed genes showed that Timothy syndrome cells clustered separately from controls. The expression of 211 genes (126 upregulated and 85 downregulated) in neurons and 136 genes (58 upregulated and 78 downregulated) in NPCs was substantially altered in Timothy syndrome cells (Fig. 2c,d and Supplementary  Table 4 ). Of the genes with altered expression in Timothy syndrome neurons, 11 were previously implicated in either ASD or intellectual disability 23, 24 ( Supplementary Table 5 ).
We also identified 223 genes (135 upregulated and 88 downregulated) whose expression was altered in Timothy syndrome relative to control neurons after depolarization. A number of the genes that were altered in Timothy syndrome cells are linked to Ca 2+ -dependent regulation of the transcription factor cAMP response-element binding (CREB) ( Fig. 2e,f) , including RPS6KA1-SIK1 (also known as RSK-MSK) and CAMKII. Other genes, such as EGR1, FOS, FOSB, GAD1 and TH, are downstream targets of CREB. In addition to TH, Progenitors   TS   T7643-7  T7643-7  T7643-7  T7643-32  T7643-32  T7643-32  T7643-32  T7643-5  T7643-5  T7643-5  T7643-5  H9  H9  H9  IM23-9 IM23-9 IM23-9 IM23-16 which encodes the rate-limiting enzyme in the production of dopamine and norepinephrine, CALY (encoding calcyon and also known as DRD1IP), another gene involved in dopamine signaling, was also upregulated in Timothy syndrome neurons. These results suggest that the mutation that causes Timothy syndrome leads to the misregulation of Ca 2+ -dependent gene expression and perturbs catecholamine signaling.
To determine whether the Timothy syndrome mutation leads to defects in neuronal differentiation, we used Fluidigm arrays to study the identity of cells generated from individuals with Timothy syndrome compared to controls (Fig. 3a) . We found a significant decrease in the fraction of neurons expressing lower-layer markers in Timothy syndrome cells relative to controls (66.7% of neurons expressed these markers in Timothy syndrome cells compared to 85.5% in controls; P < 0.001; Fig. 3b ) and an increase in the fraction of neurons expressing upper-layer markers (33.3% in Timothy syndrome cells compared to 14.5% in controls; P = 0.002; Fig. 3b) . A significantly lower proportion of Timothy syndrome cells expressing lower-layer markers (Fig. 3c) expressed SATB2 (31.0% of Timothy syndrome cells compared to 55.3% of controls; P < 0.001), and a significantly higher proportion expressed CTIP2 (BCL11B) relative to controls (8.0% of Timothy syndrome cells compared to 1.0% of controls; P = 0.01). Because SATB2 is both necessary and sufficient for the specification of callosal projection neurons 20, 21 , this finding suggests that the Timothy syndrome mutation decreases the fraction of callosal projection neurons and increases the number of cells that project to subcortical structures.
To provide additional support for these results in vivo, we measured Satb2 expression in a transgenic mouse expressing Ca v 1.2 carrying the mutation associated with Timothy syndrome type 1, expressed in the forebrain under the control of the Foxg1 promoter ( Supplementary  Fig. 9 ). Timothy syndrome-transgenic mice had a reduced number of cells expressing Satb2 in the lower cortical layers (Fig. 3d-f) , whereas Foxp1 expression ( Fig. 3g ) and the total number of neurons expressing Rbfox3 (also known as NeuN) in the cortex were unchanged. We therefore conclude that the Timothy syndrome mutation alters SATB2 expression both in vitro and in vivo. Notably, we did not observe an increase in the number of cells expressing Ctip2 (Bcl11b) in the mice expressing the Timothy syndrome channel. This could be either because of differences between in vivo and in vitro neuronal differentiation or because of species-specific differences in CTIP2 (BCL11B) regulation. CTIP2 (BCL11B) is, in fact, expressed more broadly in humans than in mice, labeling cells in the subventricular zone as well as in cortical layers II and V in humans 25 .
We also observed a significant increase in the fraction of cells that expressed TH in Timothy syndrome neuronal cultures (16.4% of Timothy syndrome cells expressed TH compared to 8.0% of controls; P = 0.03; Fig. 3a ). This agrees with our earlier finding that genes involved in catecholamine synthesis are misregulated in Timothy syndrome ( Fig. 2e,f) . To determine whether the Timothy syndrome mutation alters the regulation of TH, we measured TH mRNA in Timothy syndrome and control neurons following electrical activation (Fig. 4a) . After 9 h of stimulation, TH was downregulated in control neurons but was upregulated in Timothy syndrome neurons, indicating that the Timothy syndrome mutation prevents downregulation of TH in response to prolonged electrical activity.
To investigate whether this increase in TH mRNA has functional consequences, we measured expression of tyrosine hydroxylase (TH) protein using an antibody specific for TH. We found that 15.03% ± 0.92% (mean ± s.e.m., n = 9 differentiations) of the Timothy syndrome neurons expressed TH, whereas only 2.52% ± 0.62% (mean ± s.e.m., n = 7 differentiations) of the control cultures expressed the protein ( Fig. 4b-d ; t test, P < 0.001). Cultures generated from an individual with 22q11.2 deletion syndrome, which is another neurodevelopmental disorder, did not show increased expression of TH, indicating that CAMK2  VGLUT1  VGLUT2  VGLUT3  GAD65  GAD67  VGAT  CALB1  CALB2  PVALB  TH  DDC  GCH1  DRD1  DRD2   DARPP32   FOXP1  ETV1  SATB2  CTIP2  CUX1 this defect is relatively specific for Timothy syndrome (Fig. 4c) . To determine whether this change in TH protein caused an increase in the production of catecholamines, we used HPLC to measure the amount of norepinephrine and dopamine in the media collected from the neuronal cultures. We found that the Timothy syndrome neurons secreted 3.5× more norepinephrine (34.7 × 10 −5 ± 4.02 × 10 −5 pg µl −1 per neuron for Timothy syndrome compared to 9.79 × 10 −5 ± 1.83 × 10 −5 pg µl −1 per neuron for controls; t test, P = 0.004) and 2.3× more dopamine (4.56 × 10 −5 ± 0.36 × 10 −5 pg µl −1 per neuron for Timothy syndrome compared to 2.05 × 10 −5 ± 0.24 × 10 −5 pg µl −1 per neuron; t test, P = 0.001) than control lines, strongly suggesting that the Timothy syndrome mutation leads to increased TH expression and to an excess secretion of catecholamines (Fig. 4e) . We next investigated the cellular identity of neurons that produce TH in Timothy syndrome and control cultures. In both control and Timothy syndrome cultures, TH-expressing neurons were not stained with antibodies to forkhead box A2 (FOXA2) or engrailed homeobox 1 (EN1), markers of midbrain neurons, or to γ-aminobutyric acid (GABA), a marker for dopaminergic olfactory neurons in the forebrain (Fig. 4f) . Using Fluidigm chip analysis, we found that TH expression was not confined to any specific class of neurons, although TH + neurons derived from individuals with Timothy syndrome were more likely to co-express excitatory markers and dopamine-related genes (Fig. 4g) . This suggests that the Timothy syndrome channel does not promote a catecholaminergic cell fate but instead increases the expression of TH in a subpopulation of cortical cell types. Notably, we did not observe an increase in TH staining in the cortex of transgenic mice expressing the Timothy syndrome channel. This probably reflects the low homology between the promoter regions of mouse and human TH and differences in gene regulation 26, 27 .
Finally, to determine whether the increase in TH expression was reversible and was a result of L-type-channel activity, we treated 39-dayold iPSC-derived neurons from individuals with Timothy syndrome with L-type-channel blockers. The conventional L-type channel blocker nimodipine failed to reverse the excess expression of TH in neurons in these cells. However, treatment with roscovitine, a compound that increases inactivation of the L-type channel, caused a 68% reduction in the proportion of TH + neurons ( Fig. 4h,i ; P < 0.01 two-way analysis of variance (ANOVA); n = 3,975 neurons from three Timothy syndrome iPS lines and n = 2,679 from three control lines) without affecting the fraction of cells expressing MAP2. This is consistent with earlier studies of iPSC-derived cardiomyocytes 12 from individuals with Timothy syndrome, showing that roscovitine [2] [3] [4] can reduce the prolongation of the cardiac action potential in these cells. This result suggests that the increase in TH expression results from lack of inactivation of the channels containing the Timothy syndrome mutation and, further, that restoring channel inactivation in mature neurons can decrease the abnormal expression of TH in the cells of individuals with Timothy syndrome.
In this study, we show that iPSC-derived neurons from individuals with Timothy syndrome can be used to identify cellular phenotypes associated with a neurodevelopmental disorder. These findings provide insight both into the function of Ca v 1.2 in the developing human brain and its role in the pathogenesis of psychiatric diseases. We report an increase in the amplitude of Ca 2+ elevations in Timothy syndrome NPCs and neurons, indicating that loss of inactivation in a single splice variant of Ca v 1.2 can have substantial effects on neuronal signaling. A consequence of this defect was a change in activity-dependent gene expression and an increase in cells producing norepinephrine and dopamine, consistent with previous experiments showing that dopaminergic specification is activity dependent 28 . The Timothy syndrome mutation also caused a decrease in the proportion of cells expressing lower-cortical-layer markers and a decrease in the proportion of cells expressing markers for callosal projection neurons. Some, but not all, of these defects were recapitulated in a mouse expressing the channel with the Timothy syndrome mutation, suggesting that species-specific differences in gene regulation can change the cellular phenotypes associated with a disease 26, 27 . A key question is whether these cellular defects help to explain the developmental delay and ASD seen in individuals with Timothy syndrome. The reduction in cortical projecting neurons in Timothy syndrome is consistent with the emerging view that ASDs arise from defects in connectivity between cortical areas 29, 30 and agrees with studies that reported a decreased size of the corpus callosum in ASD 31 . Ectopic production of TH and a subsequent increase in catecholamine synthesis is consistent with findings from valproic-acid based models of ASD 32 and postmortem studies of individuals with schizophrenia 33 . As catecholamines have a key role in sensory gating and in social behavior, an increase in their synthesis could play a role in the pathophysiology of ASDs.
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